Quetiapine Fumarate
- Product NDC
- 0615-7846
- 11-digit product format
- 006157846
- Labeler code
- 0615
- Product ID
- 0615-7846_9259cf91-0894-4e2b-8565-aa808fbd3824
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Quetiapine Fumarate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA077745
- Marketing category
- ANDA
- Marketing start
- 2014-03-12
- Marketing end
- 0000-00-00
- Substance
- QUETIAPINE FUMARATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7846-05 | 2021-08-31 | C162847 | 48780-1 | 9d75b9d0-2758-f424-e053-dadaa90a57ce | 13cd915a-ffea-4223-a94d-efe3dcb5fe5f |
| 0615-7846-30 | 2021-08-31 | C162847 | 48780-1 | 9d75b9d0-2758-f424-e053-dadaa90a57ce | 13cd915a-ffea-4223-a94d-efe3dcb5fe5f |
| 0615-7846-39 | 2021-08-31 | C162847 | 48780-1 | 9d75b9d0-2758-f424-e053-dadaa90a57ce | 13cd915a-ffea-4223-a94d-efe3dcb5fe5f |
| 0615-7846-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2758-f424-e053-dadaa90a57ce | 13cd915a-ffea-4223-a94d-efe3dcb5fe5f |
| 0615-7846-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2758-f424-e053-dadaa90a57ce | 13cd915a-ffea-4223-a94d-efe3dcb5fe5f |
| 0615-7846-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2758-f424-e053-dadaa90a57ce | 13cd915a-ffea-4223-a94d-efe3dcb5fe5f |